- Home
- SSYS vs PLRX Comparison
SSYS vs PLRX Comparison
Compare SSYS & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSYS
- PLRX
- Stock Information
- Founded
- SSYS 1989
- PLRX 2015
- Country
- SSYS United States
- PLRX United States
- Employees
- SSYS N/A
- PLRX N/A
- Industry
- SSYS Computer peripheral equipment
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- SSYS Technology
- PLRX Health Care
- Exchange
- SSYS Nasdaq
- PLRX Nasdaq
- Market Cap
- SSYS 534.6M
- PLRX 641.5M
- IPO Year
- SSYS 1994
- PLRX 2020
- Fundamental
- Price
- SSYS $9.58
- PLRX $13.18
- Analyst Decision
- SSYS Strong Buy
- PLRX Strong Buy
- Analyst Count
- SSYS 4
- PLRX 7
- Target Price
- SSYS $11.50
- PLRX $40.50
- AVG Volume (30 Days)
- SSYS 789.7K
- PLRX 447.1K
- Earning Date
- SSYS 11-13-2024
- PLRX 11-07-2024
- Dividend Yield
- SSYS N/A
- PLRX N/A
- EPS Growth
- SSYS N/A
- PLRX N/A
- EPS
- SSYS N/A
- PLRX N/A
- Revenue
- SSYS $578,436,000.00
- PLRX N/A
- Revenue This Year
- SSYS N/A
- PLRX N/A
- Revenue Next Year
- SSYS $4.53
- PLRX $585.71
- P/E Ratio
- SSYS N/A
- PLRX N/A
- Revenue Growth
- SSYS N/A
- PLRX N/A
- 52 Week Low
- SSYS $6.05
- PLRX $10.22
- 52 Week High
- SSYS $14.93
- PLRX $19.62
- Technical
- Relative Strength Index (RSI)
- SSYS 61.08
- PLRX 41.24
- Support Level
- SSYS $8.80
- PLRX $12.01
- Resistance Level
- SSYS $9.49
- PLRX $12.94
- Average True Range (ATR)
- SSYS 0.50
- PLRX 0.87
- MACD
- SSYS 0.11
- PLRX -0.29
- Stochastic Oscillator
- SSYS 60.81
- PLRX 21.66
About SSYS Stratasys Ltd. (Israel)
Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.